Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
College of Physicians & Surgeons Dean Lee Goldman discusses his new book, which examines the role DNA plays in attempting to treat diabetes, obesity, and cardiovascular disease.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
As part of a nationwide NIH research program, a group of CUMC researchers will begin incorporating genomic information into electronic health records of thousands of patients.